Chronic exposure of B16 mouse melanoma cells to IFN-γ stimulates the expression of the checkpoint receptors PD-1, CTLA-4, LAG-3, and of TIM-3 ligands, as well as the resistance to combined ICB therapies in tumor grafts (62). Here, CTLA4 is linked to neoplasm.